Browse > Article

Epigenetic Study of XIST Gene from Female and Male Cells by Pyrosequencing  

Kim, Hwan-Hee (Functional Genomics Lab, CHA Stem Cell Research Institute, School of Medicine, CHA University)
Yun, Yeo-Jin (Functional Genomics Lab, CHA Stem Cell Research Institute, School of Medicine, CHA University)
Song, Min-Ae (Functional Genomics Lab, CHA Stem Cell Research Institute, School of Medicine, CHA University)
Lee, Su-Man (Functional Genomics Lab, CHA Stem Cell Research Institute, School of Medicine, CHA University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.37, no.1, 2010 , pp. 25-31 More about this Journal
Abstract
Objective: X inactivation is the silencing one of the two X chromosomes in female mammals for gene dosage on the X-chromosome between female and male. X inactivation is controlled by X inactive-specific transcript (XIST) gene, untranslated RNA. XIST is expressed only from the inactive X (Xi), not expressed from the active X (Xa). The Xist promoter is methylated on the silent Xist allele on the Xa in somatic cells, and less methylated on the Xist-expressing Xi. We investigated the difference of XIST methylation pattern of the promoter and 5'-region of XIST from male (XY) and female (XX) subjects. Methods: The direct quantification of XIST methylation is required for clinical application of normal XX and XY blood. Methylation percentage of eight CpG sites (-1696, -1679, -1475, -1473, -1469, +947, +956, +971) of XIST gene were diagnosed by pyrosequencing. Results: We directly quantitated the methylation percentage of the promoter and 5'-end of XIST by pyrosequencing. The average methylation percentages at CpG6-8 sites (+947, +956, +971) were 45.2% at CpG6, 49.9% at CpG7, and 44.2% at CpG8 from normal female and normal male were 90.6%, 96.7%, 87.8%, respectively. Nether CpG 1-5sites (-1696, -1679, -1475, -1473, -1469) had any effect on XX and XY. Conclusion: This method is sensitive for quantifying the small percentage change in the methylation status of XIST, and may be used for diagnosis.
Keywords
XIST; CpG; DNA methylation; Pyrosequencing;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific pcr: A novel pcr assay for methylation status of cpg islands. Proc Natl Acad Sci U S A 1996; 93: 9821-6.   DOI   ScienceOn
2 Heard E. Recent advances in x-chromosome inactivation. Curr Opin Cell Biol 2004; 16: 247-55.   DOI   ScienceOn
3 Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992; 89: 1827-31.   DOI   ScienceOn
4 Camargo M, Wang N. Cytogenetic evidence for the absence of an inactivated x chromosome in a human female (xx) breast carcinoma cell line. Hum Genet 1980; 55: 81-5.   DOI
5 Brown CJ, Hendrich BD, Rupert JL, Lafreniere RG, Xing Y, Lawrence J, et al. The human xist gene: Analysis of a 17 kb inactive x-specific rna that contains conserved repeats and is highly localized within the nucleus. Cell 1992; 71: 527-42.   DOI   ScienceOn
6 Rudas M, Schmidinger M, Wenzel C, Okamoto I, Budinsky A, Fazeny B, et al. Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 2000; 121: 190-3.   DOI   ScienceOn
7 Laner T, Schulz WA, Engers R, Muller M, Florl AR. Hypomethylation of the xist gene promoter in prostate cancer. Oncol Res 2005; 15: 257-64.   DOI
8 Oktem O, Paduch DA, Xu K, Mielnik A, Oktay K. Normal female phenotype and ovarian development despite the ovarian expression of the sex-determining region of y chromosome (sry) in a 46,xx/69,xxy diploid/triploid mosaic child conceived after in vitro fertilization-intracytoplasmic sperm injection. J Clin Endocrinol Metab 2007; 92: 1008-14.   DOI
9 Ronaghi M, Nygren M, Lundeberg J, Nyren P. Analyses of secondary structures in DNA by pyrosequencing. Anal Biochem 1999; 267: 65-71.   DOI   ScienceOn
10 Reed K, Poulin ML, Yan L, Parissenti AM. Comparison of bisulfite sequencing pcr with pyrosequencing for measuring differences in DNA methylation. Anal Biochem 397: 96-106.
11 Dutrillaux B, Muleris M, Seureau MG. Imbalance of sex chromosomes, with gain of early-replicating x, in human solid tumors. Int J Cancer 1986; 38: 475-9.   DOI
12 Wang N, Cedrone E, Skuse GR, Insel R, Dry J. Two identical active x chromosomes in human mammary carcinoma cells. Cancer Genet Cytogenet 1990; 46: 271-80.   DOI   ScienceOn
13 Teixeira MR, Pandis N, Dietrich CU, Reed W, Andersen J, Qvist H, et al. Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosomes Cancer 1998; 23: 16-20.   DOI   ScienceOn
14 Dupont JM, Tost J, Jammes H, Gut IG. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 333: 119-27.   DOI   ScienceOn
15 Yu-Mi Jeong JHP, Sook-Hwan Lee, Tae-Gyu Chung, Yong Sung Kim, Nam-Soon Kim et al. The study of x chromosome inactivartion mechanism in klinefelter's syndrome by cdna microarray experiment. Genomics & informatics 2004; 2(1): 30-5.   과학기술학회마을
16 Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-7.   DOI   ScienceOn
17 Schumacher A, Kapranov P, Kaminsky Z, Flanagan J, Assadzadeh A, Yau P, et al. Microarray-based DNA methylation profiling: Technology and applications. Nucleic Acids Res 2006; 34: 528-42.   DOI   ScienceOn
18 Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 2: 2265-75.   DOI   ScienceOn
19 Turner JM, Mahadevaiah SK, Elliott DJ, Garchon HJ, Pehrson JR, Jaenisch R, et al. Meiotic sex chromosome inactivation in male mice with targeted disruptions of xist. J Cell Sci 2002; 115: 4097-105.   DOI   ScienceOn
20 Beard C, Li E, Jaenisch R. Loss of methylation activates xist in somatic but not in embryonic cells. Genes Dev 1995; 9: 2325-34.
21 Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. Xist rna and the mechanism of x chromosome inactivation. Annu Rev Genet 2002; 36: 233-78.   DOI   ScienceOn
22 Lyon MF. Gene action in the x-chromosome of the mouse (mus musculus l.). Nature 1961; 190: 372-3.   DOI   ScienceOn
23 Spatz A, Borg C, Feunteun J. X-chromosome genetics and human cancer. Nat Rev Cancer 2004; 4: 617-29.   DOI   ScienceOn
24 Heard E, Disteche CM. Dosage compensation in mammals: Fine-tuning the expression of the x chromosome. Genes Dev 2006; 20: 1848-67.   DOI   ScienceOn